Arachidoyl Ethanolamide – 5 mg

Brand:
Cayman
CAS:
94421-69-9
Storage:
-20
UN-No:
Non-Hazardous - /

The endocannabinoids present a rich system of central cannabinoid (CB1), peripheral cannabinoid (CB2), and non-CB receptor-mediated pharmacology that has stimulated research in many fields including memory, weight loss and appetite, neurodegeneration, tumor surveillance, analgesia, and inflammation.{7991,7912} Arachidoyl ethanolamide is one of the saturated fatty acyl ethanolamides devoid of classical (CB1/CB2) activity. Arachidoyl ethanolamide does not bind to the murine CB1 receptor{9580} and does not compete with anandamide as a substrate for the endocannabinoid hydrolytic enzyme fatty acid amide hydrolase.{9532} Non-CB receptor-mediated pharmacology of the saturated ethanolamides is still being elucidated.{10785}  

 

Available on backorder

SKU: 10005765 - 5 mg Category:

Description

A saturated fatty acyl ethanolamide devoid of classical (CB1/CB2) activity; does not bind to the murine CB1 receptor and does not compete with AEA as a substrate for FAAH; a non-CB receptor-mediated pharmacology is still being elucidated


Formal name: N-(2-hydroxyethyl)-eicosanamide

Synonyms:  N-Arachidoylethanolamine

Molecular weight: 355.6

CAS: 94421-69-9

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Lipids|Fatty Amides||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids